Works by Armand, Philippe

Results: 54
    1
    2

    Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.

    Published in:
    Oncologist, 2020, v. 25, n. 10, p. 878, doi. 10.1634/theoncologist.2020-0167
    By:
    • Carreau, Nicole A.;
    • Pail, Orrin;
    • Armand, Philippe;
    • Merryman, Reid;
    • Advani, Ranjana H.;
    • Spinner, Michael A.;
    • Herrera, Alex;
    • Chen, Robert;
    • Tomassetti, Sarah;
    • Ramchandren, Radhakrishnan;
    • Hamid, Muhammad S.;
    • Assouline, Sarit;
    • Santiago, Raoul;
    • Wagner‐Johnston, Nina;
    • Paul, Suman;
    • Svoboda, Jakub;
    • Bair, Steven;
    • Barta, Stefan;
    • Liu, Yang;
    • Nathan, Sunita
    Publication type:
    Article
    3

    Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis.

    Published in:
    Oncologist, 2019, v. 24, n. 7, p. 955, doi. 10.1634/theoncologist.2018-0538
    By:
    • Bair, Steven M.;
    • Strelec, Lauren E.;
    • Feldman, Tatyana A.;
    • Ahmed, Gulrayz;
    • Armand, Philippe;
    • Shah, Nirav N.;
    • Singavi, Arun N.;
    • Reddy, Nishitha;
    • Khan, Nadia;
    • Andreadis, Charalambos;
    • Vu, Khoan;
    • Huntington, Scott F.;
    • Giri, Smith;
    • Ujjani, Chaitra;
    • Howlett, Christina;
    • Faheem, Malik;
    • Youngman, Matthew R.;
    • Nasta, Sunita D.;
    • Landsburg, Daniel J.;
    • Schuster, Stephen J.
    Publication type:
    Article
    4
    5

    Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54512-7
    By:
    • Paczkowska, Julia;
    • Tang, Ming;
    • Wright, Kyle T.;
    • Song, Li;
    • Luu, Kelsey;
    • Shanmugam, Vignesh;
    • Welsh, Emma L.;
    • Weirather, Jason L.;
    • Besson, Naomi;
    • Olszewski, Harrison;
    • Porter, Billie A.;
    • Pfaff, Kathleen L.;
    • Redd, Robert A.;
    • Cader, Fathima Zumla;
    • Mandato, Elisa;
    • Ouyang, Jing;
    • Calabretta, Eleonora;
    • Bai, Gali;
    • Lawton, Lee N.;
    • Armand, Philippe
    Publication type:
    Article
    6
    7
    8

    Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 11, p. 1244, doi. 10.1002/ajh.25627
    By:
    • Ghobrial, Irene M.;
    • Liu, Chia‐Jen;
    • Zavidij, Oksana;
    • Azab, Abdel K.;
    • Baz, Rachid;
    • Laubach, Jacob P.;
    • Mishima, Yuji;
    • Armand, Philippe;
    • Munshi, Nikhil C.;
    • Basile, Frank;
    • Constantine, Michael;
    • Vredenburgh, James;
    • Boruchov, Adam;
    • Crilley, Pamela;
    • Henrick, Patrick M.;
    • Hornburg, Kalvis T. V.;
    • Leblebjian, Houry;
    • Chuma, Stacey;
    • Reyes, Kaitlen;
    • Noonan, Kimberly
    Publication type:
    Article
    9
    10

    Does iron overload really matter in stem cell transplantation?

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 6, p. 569, doi. 10.1002/ajh.23188
    By:
    • Armand, Philippe;
    • Sainvil, Marie-Michele;
    • Kim, Haesook T.;
    • Rhodes, Joanna;
    • Cutler, Corey;
    • Ho, Vincent T.;
    • Koreth, John;
    • Alyea, Edwin P.;
    • Neufeld, Ellis J.;
    • Kwong, Raymond Y.;
    • Soiffer, Robert J.;
    • Antin, Joseph H.
    Publication type:
    Article
    11
    12

    Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00788-9
    By:
    • Gadi, Deepti;
    • Martindale, Stephen P.;
    • Chiu, Pui Yan;
    • Khalsa, Jasneet;
    • Chen, Pei-Hsuan;
    • Fernandes, Stacey M.;
    • Wang, Zixu;
    • Tyekucheva, Svitlana;
    • Machado, John-Hanson;
    • Fisher, David C.;
    • Armand, Philippe;
    • Davids, Matthew S.;
    • Rodig, Scott;
    • Sherry, Barbara;
    • Brown, Jennifer R.
    Publication type:
    Article
    13

    Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 6, p. 1130, doi. 10.3109/10428194.2011.645208
    By:
    • Lane, Andrew A.;
    • Armand, Philippe;
    • Feng, Yang;
    • Neuberg, Donna S.;
    • Abramson, Jeremy S.;
    • Brown, Jennifer R.;
    • Fisher, David C.;
    • LaCasce, Ann S.;
    • Jacobsen, Eric D.;
    • McAfee, Steven L.;
    • Spitzer, Thomas R.;
    • Freedman, Arnold S.;
    • Chen, Yi-Bin
    Publication type:
    Article
    14

    Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma.

    Published in:
    HemaSphere, 2024, v. 8, n. 4, p. 1, doi. 10.1002/hem3.47
    By:
    • Merryman, Reid W.;
    • Rhoades, Justin;
    • Xiong, Kan;
    • Redd, Robert A.;
    • Antel, Katherine;
    • An, Hyun Hwan;
    • McDonough, Mikaela;
    • Guerrero, Liliana;
    • Crnjac, Andela;
    • Sridhar, Sainetra;
    • Blewett, Timothy;
    • Cheng, Ju;
    • Dahi, Parastoo B.;
    • Nieto, Yago;
    • Joyce, Robin M.;
    • Chen, Yi‐Bin;
    • Herrera, Alex F.;
    • Armand, Philippe;
    • Murakami, Mark;
    • Adalsteinsson, Viktor A.
    Publication type:
    Article
    15
    16

    P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD-1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA.

    Published in:
    2023
    By:
    • Johnson, Nathalie;
    • Lavie, David;
    • Borchmann, Peter;
    • Gregory, Gareth;
    • Herrera, Alex F.;
    • Minuk, Leonard;
    • Vucinic, Vladan;
    • Armand, Philippe;
    • Avigdor, Abraham;
    • Gasiorowski, Robin;
    • Herishanu, Yair;
    • Keane, Colm;
    • Kuruvilla, John;
    • Marceau West, Rachel;
    • Pillai, Pallavi;
    • Marinello, Patricia;
    • Timmerman, John
    Publication type:
    Abstract
    17

    P061: Safety and Dose‐Expansion Study of Combination Favezelimab (anti–LAG‐3) Plus Pembrolizumab in Anti–PD‐1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, p. 28, doi. 10.1097/01.HS9.0000890812.66186.e8
    By:
    • Borchmann, Peter;
    • Johnson, Nathalie A.;
    • Lavie, David;
    • Gregory, Gareth;
    • Herrera, Alex F.;
    • Minuk, Leonard;
    • Vucinic, Vladan;
    • Armand, Philippe;
    • Avigdor, Abraham;
    • Gasiorowski, Robin;
    • Herishanu, Yair;
    • Keane, Colm;
    • Kuruvilla, John;
    • Palcza, John;
    • Pillai, Pallavi;
    • Nahar, Akash;
    • Timmerman, John
    Publication type:
    Article
    18
    19

    Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 6, p. 783, doi. 10.1080/10428194.2024.2317343
    By:
    • Nemec, Ronald;
    • Scherrer-Crosbie, Marielle;
    • Abramson, Jeremy S.;
    • Redd, Robert;
    • Gilman, Hannah K.;
    • Ho, Terry;
    • Wu, Jessica;
    • Heemelaar, Julius;
    • Neuberg, Donna;
    • Hochberg, Ephraim P.;
    • Barnes, Jeffrey A.;
    • Armand, Philippe;
    • Jacobsen, Eric D.;
    • Jacobson, Caron A.;
    • Kim, Austin I.;
    • Friedman, Robb S.;
    • LaCasce, Ann S.;
    • Neilan, Tomas G.;
    • Soumerai, Jacob D.
    Publication type:
    Article
    20

    Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 130, doi. 10.1080/10428194.2022.2136956
    By:
    • Kuruvilla, John;
    • Armand, Philippe;
    • Hamadani, Mehdi;
    • Kline, Justin;
    • Moskowitz, Craig H.;
    • Avigan, David;
    • Brody, Joshua D.;
    • Ribrag, Vincent;
    • Herrera, Alex F.;
    • Morschhauser, Franck;
    • Kanate, Abraham;
    • Zinzani, Pier Luigi;
    • Bitran, Jacob;
    • Ghesquieres, Herve;
    • Schuster, Stephen J.;
    • Farooqui, Mohammed;
    • Marinello, Patricia;
    • Bartlett, Nancy L.
    Publication type:
    Article
    21

    Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2912, doi. 10.1080/10428194.2022.2103808
    By:
    • Taranto, Eleanor;
    • Redd, Robert;
    • Jeter, Erin;
    • McHugh, Kristin;
    • Crombie, Jennifer L.;
    • Fisher, David C.;
    • Jacobsen, Eric;
    • Jacobson, Caron A.;
    • Kim, Austin I.;
    • LaCasce, Ann S.;
    • Odejide, Oreofe O.;
    • Dahi, Parastoo B.;
    • Nieto, Yago;
    • Joyce, Robin M.;
    • Chen, Yi-Bin;
    • Bonjoc, Kimberley-Jane C.;
    • Chaudhry, Ammar;
    • Herrera, Alex F.;
    • Armand, Philippe;
    • Merryman, Reid W.
    Publication type:
    Article
    22
    23
    24

    Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis.

    Published in:
    2020
    By:
    • Zinzani, Pier Luigi;
    • Chen, Robert;
    • Armand, Philippe;
    • Johnson, Nathalie A.;
    • Brice, Pauline;
    • Radford, John;
    • Ribrag, Vincent;
    • Molin, Daniel;
    • Vassilakopoulos, Theodoros P.;
    • Tomita, Akihiro;
    • von Tresckow, Bastian;
    • Shipp, Margaret A.;
    • Lin, Jianxin;
    • Nahar, Akash;
    • Balakumaran, Arun;
    • Moskowitz, Craig H.
    Publication type:
    Letter
    25
    26

    Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 993, doi. 10.3109/10428194.2014.941835
    By:
    • Jacobsen, Eric;
    • Pozdnyakova, Olga;
    • Redd, Robert;
    • Fisher, David C.;
    • Dorfman, David M.;
    • Dal Cin, Paola;
    • LaCasce, Ann;
    • Armand, Philippe;
    • Hochberg, Ephraim;
    • Cote, Gregory;
    • Shahsafaei, Ali;
    • Neuberg, Donna;
    • Brown, Jennifer R.;
    • Freedman, Arnold S.
    Publication type:
    Article
    27

    Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 1, p. 123, doi. 10.1111/bjh.12439
    By:
    • Armand, Philippe;
    • Oki, Yasuhiro;
    • Neuberg, Donna S.;
    • Faham, Malek;
    • Cummings, Craig;
    • Klinger, Mark;
    • Weng, Li;
    • Bhattar, Sangeetha;
    • LaCasce, Ann S.;
    • Jacobsen, Eric D.;
    • Davids, Matthew S.;
    • Jacobson, Caron;
    • Fisher, David C.;
    • Brown, Jennifer R.;
    • Fowler, Nathan H.;
    • Alma Rodriguez, M.;
    • Wallace, Michael J.;
    • Neelapu, Sattva S.;
    • Rodig, Scott;
    • Younes, Anas
    Publication type:
    Article
    28

    Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.

    Published in:
    British Journal of Haematology, 2013, v. 160, n. 5, p. 608, doi. 10.1111/bjh.12176
    By:
    • Armand, Philippe;
    • Welch, Sarah;
    • Kim, Haesook T.;
    • LaCasce, Ann S.;
    • Jacobsen, Eric D.;
    • Davids, Matthew S.;
    • Jacobson, Caron;
    • Fisher, David C.;
    • Brown, Jennifer R.;
    • Coughlin, Erin;
    • Freedman, Arnold S.;
    • Chen, Yi‐Bin
    Publication type:
    Article
    29
    30

    Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.

    Published in:
    Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac417
    By:
    • Sherman, Amy C;
    • Crombie, Jennifer L;
    • Cheng, ChiAn;
    • Desjardins, Michaël;
    • Zhou, Guohai;
    • Ometoruwa, Omolola;
    • Rooks, Rebecca;
    • Senussi, Yasmeen;
    • McDonough, Mikaela;
    • Guerrero, Liliana I;
    • Kupelian, John;
    • Doss-Gollin, Simon;
    • Smolen, Kinga K;
    • Haren, Simon D van;
    • Armand, Philippe;
    • Levy, Ofer;
    • Walt, David R;
    • Baden, Lindsey R;
    • Issa, Nicolas C
    Publication type:
    Article
    31
    32
    33
    34
    35

    Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 2, p. 226, doi. 10.1002/cncr.29023
    By:
    • Chen, Yi‐Bin;
    • Batchelor, Tracy;
    • Li, Shuli;
    • Hochberg, Ephraim;
    • Brezina, Mark;
    • Jones, Sooae;
    • Del Rio, Candice;
    • Curtis, Morgan;
    • Ballen, Karen K.;
    • Barnes, Jeffrey;
    • Chi, Andrew S.;
    • Dietrich, Jorg;
    • Driscoll, Jessica;
    • Gertsner, Elizabeth R.;
    • Hochberg, Fred;
    • LaCasce, Ann S.;
    • McAfee, Steven L.;
    • Spitzer, Thomas R.;
    • Nayak, Lakshmi;
    • Armand, Philippe
    Publication type:
    Article
    36
    37

    Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 5, p. 774, doi. 10.1111/bjh.19037
    By:
    • Ryan, Christine E.;
    • Zon, Rebecca L.;
    • Redd, Robert;
    • Fisher, David C.;
    • Shouval, Roni;
    • Kumar, Anita;
    • Crombie, Jennifer L.;
    • Sadrzadeh, Hossein;
    • Kim, Austin I.;
    • Nayak, Lakshmi;
    • Chukwueke, Ugonma N.;
    • Jacobson, Caron A.;
    • Frigault, Matthew J.;
    • Palomba, M. Lia;
    • Armand, Philippe;
    • Epstein‐Peterson, Zachary;
    • Merryman, Reid W.
    Publication type:
    Article
    38

    Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 44, doi. 10.1111/bjh.16756
    By:
    • Carreau, Nicole A.;
    • Armand, Philippe;
    • Merryman, Reid W.;
    • Advani, Ranjana H.;
    • Spinner, Michael A.;
    • Herrera, Alex F.;
    • Ramchandren, Radhakrishnan;
    • Hamid, Muhammad S.;
    • Assouline, Sarit;
    • Santiago, Raoul;
    • Wagner‐Johnston, Nina;
    • Paul, Suman;
    • Svoboda, Jakub;
    • Bair, Steven M.;
    • Barta, Stefan K.;
    • Nathan, Sunita;
    • Karmali, Reem;
    • Torka, Pallawi;
    • David, Kevin;
    • Lansigan, Frederick
    Publication type:
    Article
    39

    Pembrolizumab in relapsed or refractory Richter syndrome.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 2, p. e117, doi. 10.1111/bjh.16762
    By:
    • Armand, Philippe;
    • Murawski, Niels;
    • Molin, Daniel;
    • Zain, Jasmine;
    • Eichhorst, Barbara;
    • Gulbas, Zafer;
    • Hawkes, Eliza A.;
    • Pagel, John M.;
    • Phillips, Tycel;
    • Ribrag, Vincent;
    • Svoboda, Jakub;
    • Stathis, Anastasios;
    • Chatterjee, Arkendu;
    • Orlowski, Robert;
    • Marinello, Patricia;
    • Christian, Beth
    Publication type:
    Article
    40
    41
    42

    Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 5, p. 841, doi. 10.1111/bjh.14311
    By:
    • Herrera, Alex F.;
    • Kim, Haesook T.;
    • Kong, Katherine A.;
    • Faham, Malek;
    • Sun, Heather;
    • Sohani, Aliyah R.;
    • Alyea, Edwin P.;
    • Carlton, Victoria E.;
    • Chen, Yi ‐ Bin;
    • Cutler, Corey S.;
    • Ho, Vincent T.;
    • Koreth, John;
    • Kotwaliwale, Chitra;
    • Nikiforow, Sarah;
    • Ritz, Jerome;
    • Rodig, Scott J.;
    • Soiffer, Robert J.;
    • Antin, Joseph H.;
    • Armand, Philippe
    Publication type:
    Article
    43

    The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.

    Published in:
    British Journal of Haematology, 2016, v. 173, n. 1, p. 96, doi. 10.1111/bjh.13931
    By:
    • Armand, Philippe;
    • Kim, Haesook T.;
    • Sainvil, Marie‐Michele;
    • Lange, Paulina B.;
    • Giardino, Angela A.;
    • Bachanova, Veronika;
    • Devine, Steven M.;
    • Waller, Edmund K.;
    • Jagirdar, Neera;
    • Herrera, Alex F.;
    • Cutler, Corey;
    • Ho, Vincent T.;
    • Koreth, John;
    • Alyea, Edwin P.;
    • McAfee, Steven L.;
    • Soiffer, Robert J.;
    • Chen, Yi‐Bin;
    • Antin, Joseph H.
    Publication type:
    Article
    44
    45
    46

    Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 528, doi. 10.1001/jama.2023.11887
    By:
    • Neilan, Tomas G.;
    • Quinaglia, Thiago;
    • Onoue, Takeshi;
    • Mahmood, Syed S.;
    • Drobni, Zsofia D.;
    • Gilman, Hannah K.;
    • Smith, Amanda;
    • Heemelaar, Julius C.;
    • Brahmbhatt, Priya;
    • Ho, Jor Sam;
    • Sama, Supraja;
    • Svoboda, Jakub;
    • Neuberg, Donna S.;
    • Abramson, Jeremy S.;
    • Hochberg, Ephraim P.;
    • Barnes, Jefferey A.;
    • Armand, Philippe;
    • Jacobsen, Eric D.;
    • Jacobson, Caron A.;
    • Kim, Austin I.
    Publication type:
    Article
    47

    HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S373, doi. 10.1016/S2152-2650(21)01854-1
    By:
    • Ansell, Stephen;
    • Bröckelmann, Paul;
    • von Keudell, Gottfried;
    • Hun Ju Lee;
    • Santoro, Armando;
    • Zinzani, Pier Luigi;
    • Collins, Graham;
    • Cohen, Jonathon;
    • De Boer, Jan Paul;
    • Kuruvilla, John;
    • Savage, Kerry;
    • Trněný, Marek;
    • Provencio, Mariano;
    • Jaeger, Ulrich;
    • Willenbacher, Wolfgang;
    • Swanink, Rene;
    • Shipp, Margaret;
    • Engert, Andreas;
    • Armand, Philippe
    Publication type:
    Article
    48

    Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S237, doi. 10.1016/S2152-2650(21)01489-0
    By:
    • Ansell, Stephen;
    • Bröckelmann, Paul;
    • von Keudell, Gottfried;
    • Lee, Hun Ju;
    • Santoro, Armando;
    • Zinzani, Pier Luigi;
    • Collins, Graham;
    • Cohen, Jonathon;
    • De Boer, Jan Paul;
    • Kuruvilla, John;
    • Savage, Kerry;
    • Trněný, Marek;
    • Provencio, Mariano;
    • Jaeger, Ulrich;
    • Willenbacher, Wolfgang;
    • Swanink, Rene;
    • Shipp, Margaret;
    • Engert, Andreas;
    • Armand, Philippe
    Publication type:
    Article
    49
    50